Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Humbert

Showing results (191-200 of 327) with videos related to

Pageof 33
Sort By:
Clinical and Experimental Immunology|March 26, 2003
Evaluation of CD4+ T cells proliferating to grass pollen in seasonal allergic subjects by flow cytometryA C Rimaniol, G Garcia, S J Till, et al.
The European Respiratory Journal|April 14, 2006
The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up studyR J Hughes, X Jais, D Bonderman, et al.
Tissue Antigens|April 1, 1989
A method of HLA class II typing using nonradioactive labelled oligonucleotidesJ F Eliaou, M Humbert, P Balaguer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 26, 2002
Plasminogen activation by blood monocytes and alveolar macrophages in primary pulmonary hypertensionI Martin, M Humbert, A Marfaing-Koka, et al.
Clinical Pharmacology and Therapeutics|May 21, 2014
CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 polymorphisms in patients with bosentan-induced liver toxicityM Roustit, X Fonrose, D Montani, et al.
The European Respiratory Journal|November 10, 2009
Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertensionL C Price, D Montani, X Jaïs, et al.
Annales Pharmaceutiques Francaises|June 23, 2022
Knowledge exchange between patient and pharmacist: A mixed methods study to explore the role of pharmacists in patient education and counseling in asthma and pulmonary arterial hypertensionS Renet, M-C Chaumais, M Gallant-Dewavrin, et al.
Plos One|June 30, 2015
Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in RatsS Jacquin, V Rincheval, B Mignotte, et al.
The European Respiratory Journal|March 2, 2005
N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertensionR Souza, H B Bogossian, M Humbert, et al.
The European Respiratory Journal|September 19, 2008
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertensionB Degano, A Yaïci, J Le Pavec, et al.
Pageof 33

Showing results (191-200 of 327) with videos related to

Sort By:
Pageof 33
Clinical and Experimental Immunology|March 26, 2003
Evaluation of CD4+ T cells proliferating to grass pollen in seasonal allergic subjects by flow cytometryA C Rimaniol, G Garcia, S J Till, et al.
The European Respiratory Journal|April 14, 2006
The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up studyR J Hughes, X Jais, D Bonderman, et al.
Tissue Antigens|April 1, 1989
A method of HLA class II typing using nonradioactive labelled oligonucleotidesJ F Eliaou, M Humbert, P Balaguer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 26, 2002
Plasminogen activation by blood monocytes and alveolar macrophages in primary pulmonary hypertensionI Martin, M Humbert, A Marfaing-Koka, et al.
Clinical Pharmacology and Therapeutics|May 21, 2014
CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 polymorphisms in patients with bosentan-induced liver toxicityM Roustit, X Fonrose, D Montani, et al.
The European Respiratory Journal|November 10, 2009
Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertensionL C Price, D Montani, X Jaïs, et al.
Annales Pharmaceutiques Francaises|June 23, 2022
Knowledge exchange between patient and pharmacist: A mixed methods study to explore the role of pharmacists in patient education and counseling in asthma and pulmonary arterial hypertensionS Renet, M-C Chaumais, M Gallant-Dewavrin, et al.
Plos One|June 30, 2015
Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in RatsS Jacquin, V Rincheval, B Mignotte, et al.
The European Respiratory Journal|March 2, 2005
N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertensionR Souza, H B Bogossian, M Humbert, et al.
The European Respiratory Journal|September 19, 2008
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertensionB Degano, A Yaïci, J Le Pavec, et al.
Pageof 33